Big TakeBig Take

The Weight-Loss Drug Boom’s Prescription Problem

View descriptionShare

Drugs like Ozempic and Wegovy have skyrocketed in popularity over the past few years. To capitalize on that demand, telehealth companies started offering compounded versions of those drugs. That’s made them easier to access, but it’s also introduced new potential risks for people recovering from eating disorders like anorexia.

On today’s Big Take podcast, Bloomberg reporter Madison Muller joins host Sarah Holder to share what she’s learned about the ways telehealth can make it easier for people to get prescriptions that could harm them.

Read more: The Weight-Loss Drug Gold Rush Has a Dangerous Prescription Problem

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Big Take

    569 clip(s)

Big Take

The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the sma 
Social links
Follow podcast
Recent clips
Browse 572 clip(s)